Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Barnes

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapineLinda M Davies, Thomas R E Barnes, Peter B Jones, et al.
Lancet (London, England)|July 31, 2007
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewTheresa H M Moore, Stanley Zammit, Anne Lingford-Hughes, et al.
Bjpsych Open|July 31, 2025
Rapid tranquillisation for psychiatric in-patients with a diagnosis of personality disorder: under-recognised issueCarol Paton, Mike J Crawford, Matthew Hartley, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2010
Lithium in bipolar and other affective disorders: prescribing practice in the UKCarol Paton, Thomas R E Barnes, Amber Shingleton-Smith, et al.
Journal of Abnormal Psychology|August 19, 2007
Gaze strategies during planning in first-episode psychosisVyv C Huddy, Tim L Hodgson, Masuma Kapasi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2007
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapyL M Davies, S Lewis, P B Jones, et al.
Biological Psychiatry|October 13, 2004
The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophreniaSamuel B Hutton, Vyv Huddy, Thomas R E Barnes, et al.
Schizophrenia Research|July 18, 2006
A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophreniaGary Price, Mara Cercignani, Manjinder S Bagary, et al.
Schizophrenia Research|October 16, 2007
A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-upDouglas Turkington, Tom Sensky, Jan Scott, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 4, 2008
Effects of cannabis use on outcomes of psychotic disorders: systematic reviewStanley Zammit, Theresa H M Moore, Anne Lingford-Hughes, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapineLinda M Davies, Thomas R E Barnes, Peter B Jones, et al.
Lancet (London, England)|July 31, 2007
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewTheresa H M Moore, Stanley Zammit, Anne Lingford-Hughes, et al.
Bjpsych Open|July 31, 2025
Rapid tranquillisation for psychiatric in-patients with a diagnosis of personality disorder: under-recognised issueCarol Paton, Mike J Crawford, Matthew Hartley, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2010
Lithium in bipolar and other affective disorders: prescribing practice in the UKCarol Paton, Thomas R E Barnes, Amber Shingleton-Smith, et al.
Journal of Abnormal Psychology|August 19, 2007
Gaze strategies during planning in first-episode psychosisVyv C Huddy, Tim L Hodgson, Masuma Kapasi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2007
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapyL M Davies, S Lewis, P B Jones, et al.
Biological Psychiatry|October 13, 2004
The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophreniaSamuel B Hutton, Vyv Huddy, Thomas R E Barnes, et al.
Schizophrenia Research|July 18, 2006
A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophreniaGary Price, Mara Cercignani, Manjinder S Bagary, et al.
Schizophrenia Research|October 16, 2007
A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-upDouglas Turkington, Tom Sensky, Jan Scott, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 4, 2008
Effects of cannabis use on outcomes of psychotic disorders: systematic reviewStanley Zammit, Theresa H M Moore, Anne Lingford-Hughes, et al.
Pageof 15